Ariad Secures Otsuka As Asian Iclusig Partner
This article was originally published in PharmAsia News
Executive Summary
Ariad has finally found an Asian partner for its leukemia drug Iclusig, entering into an alliance with Otsuka for the commercialization of the kinase inhibitor in 10 regional markets including Japan and China.